Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP802-247 in Chronic Venous Leg Ulcers (EU)
NCT01853384Phase 3Terminated
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Nov 2013
- Primary completion
- Dec 2014
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 5
01
Overview
A Phase 3 trial of HP-802-247 in venous leg ulcer (VLU), sponsored by Healthpoint Biotherapeutics. Started Nov 2013; status: terminated.
02
Drugs
HP-802-247
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT01853384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01853384.